Aktie 301126 HUNAN DAJIAWEIKANG PHARMACEUTICAL INDUSTRY CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd

Aktien

301126

CNE1000054V3

301126

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 28.05.2024 		% 5 Tage % 1. Jan.
9.75 CNY -1.12% Intraday Chart für Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd -2.40% -25.17%
22.04. Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
2023 Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 119.999994 million in funding
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Board Elections
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed the share acquisition agreement to acquire 51% stake in Shanxi Simaile Pharmaceutical Chain Co., Ltd. from Yang Jinjiang, Liu Hongming for approximately CNY 330 million.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd agreed to acquire Yinchuan Meihetai Pharmaceutical Chain Co., Ltd. from Xie Huiyang and Xie Xiaolong for approximately CNY 250 million.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 12, 2023
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Approves Final Cash Dividend for 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd cancelled the transaction announced on May 18, 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd announced that it expects to receive CNY 300 million in funding
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Proposes Final Cash Dividend for the Year 2022
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Hunan Tongjian Pharmacy to Buy 86% Stake in Local Peer For 341 Million Yuan
Hunan Tongjian Pharma to Buy 86% of Local TCM Maker For 341 Million Yuan
Certain A Shares of Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd. are subject to a Lock-Up Agreement Ending on 8-DEC-2022.
Hunan Dajiaweikang Pharma to Buy 85.7% Stake in Pharma Firm
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd signed a Share Transfer Agreement to acquire a 85.7143% stake in Hunan Tianjicaotang Pharmaceutical CO.,LTD. from Weng Xiaotao and Xiang Zhongyou for CNY 340 million.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 301126 Aktie
  4. Nachrichten Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd
  5. Andere Sprachen